{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T22:43:02Z","timestamp":1768603382368,"version":"3.49.0"},"posted":{"date-parts":[[2026,1,13]]},"group-title":"Epidemiology","reference-count":44,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,1,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Recent mechanistic evidence identifies lithium deficiency as a driver of Alzheimer\u2019s disease and related dementias (ADRD) pathogenesis. To evaluate this hypothesis in a population-based setting, we emulated a target trial comparing ADRD progression after initiation of lithium versus antiepileptic mood stabilizers among adults \u226555 years with bipolar disorder and mild neurocognitive disorder, using US Medicare claims with replication in two commercial databases.<\/jats:p>\n                <jats:p>Lithium initiation was associated with a lower 5-year risk of progression to advanced ADRD (risk ratio 0.87; 95% CI 0.78-0.99) and long-term care stay with ADRD (0.75; 0.56-0.97). Lower risks were most pronounced in patients with later stages of mild cognitive impairment. Results were consistent across sensitivity analyses and replications. Validations using linked cognitive assessments from standardized instruments strengthened confidence in findings. While results may be susceptible to residual bias, this study supports investigating lithium\u2019s potential to delay ADRD progression with randomized trials of optimized lithium formulations.<\/jats:p>","DOI":"10.64898\/2026.01.12.26343472","type":"posted-content","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:10:20Z","timestamp":1768363820000},"source":"Crossref","is-referenced-by-count":0,"title":["Lithium therapy and delayed progression of Alzheimer\u2019s disease and related dementias in patients with bipolar disorder and mild neurocognitive disorders"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6227-6796","authenticated-orcid":false,"given":"Andrew R.","family":"Weckstein","sequence":"first","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA, USA"},{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0421-3145","authenticated-orcid":false,"given":"Sinclair","family":"Carr","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA, USA"},{"name":"Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Kr\u00fcger","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA, USA"},{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goodarz","family":"Danaei","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"Department of Global Health & Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Schneeweiss","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA, USA"},{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi J.","family":"Desai","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA, USA"},{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026011603451019000_2026.01.12.26343472v1.1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41586-025-09335-x","article-title":"Lithium deficiency and the onset of Alzheimer\u2019s disease","volume":"645","year":"2025","journal-title":"Nature"},{"key":"2026011603451019000_2026.01.12.26343472v1.2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/JAD-150437","article-title":"Lithium as a Treatment for Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"48","year":"2015","journal-title":"JAD"},{"key":"2026011603451019000_2026.01.12.26343472v1.3","doi-asserted-by":"crossref","unstructured":"Singulani, M. P. et al. Lithium and disease modification: A systematic review and meta-analysis in Alzheimer\u2019s and Parkinson\u2019s disease. Ageing Research Reviews 95, 102231 (2024).","DOI":"10.1016\/j.arr.2024.102231"},{"key":"2026011603451019000_2026.01.12.26343472v1.4","doi-asserted-by":"crossref","unstructured":"Kishi, T. , Matsunaga, S. , Saito, Y. & Iwata, N . Lithium for Alzheimer\u2019s disease: Insights from a meta-analysis. Neuroscience & Biobehavioral Reviews 180, 106458 (2026).","DOI":"10.1016\/j.neubiorev.2025.106458"},{"key":"2026011603451019000_2026.01.12.26343472v1.5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003941"},{"key":"2026011603451019000_2026.01.12.26343472v1.6","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.154047"},{"key":"2026011603451019000_2026.01.12.26343472v1.7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.euroneuro.2024.04.009","article-title":"Lithium versus anticonvulsants and the risk of physical disorders \u2013 Results from a comprehensive long-term nation-wide population-based study emulating a target trial","volume":"84","year":"2024","journal-title":"European Neuropsychopharmacology"},{"key":"2026011603451019000_2026.01.12.26343472v1.8","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.4088\/JCP.15m10304","article-title":"Association Between Lithium Use and Risk of Alzheimer\u2019s Disease","volume":"78","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"2026011603451019000_2026.01.12.26343472v1.9","doi-asserted-by":"crossref","unstructured":"Kessing, L. V. , S\u00f8nderg\u00e5rd, L. , Forman, J. L. & Andersen, P. K . Lithium Treatment and Risk of Dementia. Arch Gen Psychiatry 65, 1331 (2008).","DOI":"10.1001\/archpsyc.65.11.1331"},{"key":"2026011603451019000_2026.01.12.26343472v1.10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2215-0366(25)00097-5","article-title":"Lithium as a disease-modifying drug for bipolar disorder","volume":"12","year":"2025","journal-title":"The Lancet Psychiatry"},{"key":"2026011603451019000_2026.01.12.26343472v1.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00706.x"},{"key":"2026011603451019000_2026.01.12.26343472v1.12","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwv254"},{"key":"2026011603451019000_2026.01.12.26343472v1.13","unstructured":"American Psychiatric Association. DSM-5-TR Neurocognitive Disorders Supplement. In Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (2022)."},{"key":"2026011603451019000_2026.01.12.26343472v1.14","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13859"},{"key":"2026011603451019000_2026.01.12.26343472v1.15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/HRP.0000000000000084","article-title":"Mild Neurocognitive Disorder: An Old Wine in a New Bottle","volume":"23","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"key":"2026011603451019000_2026.01.12.26343472v1.16","unstructured":"Pre-registered protocol for: Evaluating dementia progression among persons with bipolar disorder and early neurocognitive decline: a comparative real-world study. (Sep 19 2025). https:\/\/osf.io\/uxg9n\/overview"},{"key":"2026011603451019000_2026.01.12.26343472v1.17","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwaf166"},{"key":"2026011603451019000_2026.01.12.26343472v1.18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/bmjebm-2022-112134","article-title":"Promise and peril of claims-based dementia ascertainment in causal inference","volume":"28","year":"2023","journal-title":"BMJ Evidence-Based Medicine"},{"key":"2026011603451019000_2026.01.12.26343472v1.19","doi-asserted-by":"publisher","DOI":"10.1080\/01621420802716206"},{"key":"2026011603451019000_2026.01.12.26343472v1.20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/01621424.2012.703908","article-title":"The Outcome and Assessment Information Set (OASIS): A Review of Validity and Reliability","volume":"31","year":"2012","journal-title":"Home Health Care Serv Q"},{"key":"2026011603451019000_2026.01.12.26343472v1.21","doi-asserted-by":"crossref","unstructured":"Anand, P. et al. Identifying dementia severity among people living with dementia using administrative claims data. J Am Med Dir Assoc 25, 105129 (2024).","DOI":"10.1016\/j.jamda.2024.105129"},{"key":"2026011603451019000_2026.01.12.26343472v1.22","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18487"},{"key":"2026011603451019000_2026.01.12.26343472v1.23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3233\/JAD-2009-1099","article-title":"The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited","volume":"17","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"2026011603451019000_2026.01.12.26343472v1.24","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1111\/jgs.17183","article-title":"Identifying Medicare beneficiaries with dementia","volume":"69","year":"2021","journal-title":"J American Geriatrics Society"},{"key":"2026011603451019000_2026.01.12.26343472v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2012.06.002"},{"key":"2026011603451019000_2026.01.12.26343472v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2012.06.004"},{"key":"2026011603451019000_2026.01.12.26343472v1.27","doi-asserted-by":"publisher","DOI":"10.1097\/mlr.0000000000000334"},{"key":"2026011603451019000_2026.01.12.26343472v1.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2008.01944.x"},{"key":"2026011603451019000_2026.01.12.26343472v1.29","first-page":"M128","article-title":"Validation of the Minimum Data Set Cognitive Performance Scale: agreement with the Mini-Mental State Examination","volume":"50","year":"1995","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026011603451019000_2026.01.12.26343472v1.30","doi-asserted-by":"publisher","DOI":"10.1097\/01.wad.0000155068.23937.9b"},{"key":"2026011603451019000_2026.01.12.26343472v1.31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b5087"},{"key":"2026011603451019000_2026.01.12.26343472v1.32","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12805"},{"key":"2026011603451019000_2026.01.12.26343472v1.33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jagp.2021.04.014","article-title":"Low Dose Lithium Treatment of Behavioral Complications in Alzheimer\u2019s Disease: Lit-AD Randomized Clinical Trial","volume":"30","year":"2022","journal-title":"The American Journal of Geriatric Psychiatry"},{"key":"2026011603451019000_2026.01.12.26343472v1.34","doi-asserted-by":"crossref","unstructured":"Ferensztajn-Rochowiak, E. & Rybakowski, J. K . Long-Term Lithium Therapy: Side Effects and Interactions. Pharmaceuticals (Basel ) 16, 74 (2023).","DOI":"10.3390\/ph16010074"},{"key":"2026011603451019000_2026.01.12.26343472v1.35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jgs.18119","article-title":"Antiepileptic Prescribing to Persons Living with Dementia Residing in Nursing Homes: A Tale of Two Indications","volume":"71","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"2026011603451019000_2026.01.12.26343472v1.36","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/acps.13153","article-title":"Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analyses","volume":"141","year":"2020","journal-title":"Acta Psychiatr Scand"},{"key":"2026011603451019000_2026.01.12.26343472v1.37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jalz.2013.03.004","article-title":"Validity of dementia and Alzheimer\u2019s disease diagnoses in Finnish national registers","volume":"10","year":"2014","journal-title":"Alzheimer\u2019s &amp; Dementia"},{"key":"2026011603451019000_2026.01.12.26343472v1.38","doi-asserted-by":"crossref","first-page":"e70129","DOI":"10.1002\/gps.70129","article-title":"Time to Diagnosis in Dementia: A Systematic Review With Meta-Analysis","volume":"40","year":"2025","journal-title":"Int J Geriatr Psychiatry"},{"key":"2026011603451019000_2026.01.12.26343472v1.39","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.9.1136"},{"key":"2026011603451019000_2026.01.12.26343472v1.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.10.004"},{"key":"2026011603451019000_2026.01.12.26343472v1.41","first-page":"980","article-title":"Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index","volume":"73","year":"2018","journal-title":"The Journals of Gerontology: Series A"},{"key":"2026011603451019000_2026.01.12.26343472v1.42","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/jgs.19019","article-title":"A Comparison of Dementia Diagnoses and Cognitive Function Measures in Medicare Claims and the Minimum Data Set","volume":"72","year":"2024","journal-title":"J Am Geriatr Soc"},{"key":"2026011603451019000_2026.01.12.26343472v1.43","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1111\/jgs.17201","article-title":"Changes in the agreement between the Minimum Data Set and hospital Medicare claims measures of dementia","volume":"69","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"2026011603451019000_2026.01.12.26343472v1.44","doi-asserted-by":"crossref","unstructured":"Cashin, A. G. et al. Transparent Reporting of Observational Studies Emulating a Target Trial\u2014The TARGET Statement. JAMA 334, 1084 (2025).","DOI":"10.1001\/jama.2025.13350"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.01.12.26343472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:45:27Z","timestamp":1768563927000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.01.12.26343472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":44,"URL":"https:\/\/doi.org\/10.64898\/2026.01.12.26343472","relation":{},"subject":[],"published":{"date-parts":[[2026,1,13]]},"subtype":"preprint"}}